Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;399(10103):1685–99.
Article
Google Scholar
Di Cesare E, Battisti S, Di Sibio A, et al. Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). Eur J Radiol. 2013;82(6):e268–73.
Article
PubMed
Google Scholar
Matucci-Cerinic M, Giacomelli R, Pignone A, Cagnoni ML, Generini S, Casale R, et al. Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma). Ann Rheum Dis. 2001;60(5):487–94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cipriani P, Marrelli A, Liakouli V, Di Benedetto P, Giacomelli R. Cellular players in angiogenesis during the course of systemic sclerosis. Autoimmun Rev. 2011;10(10):641–6.
Article
CAS
PubMed
Google Scholar
Giacomelli R, Di Cesare E, Cipriani P, Ruscitti P, Di Sibio A, Liakouli V, et al. Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset. Int J Rheum Dis. 2017;20(9):1247–60.
Article
CAS
PubMed
Google Scholar
Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913.
Article
CAS
PubMed
PubMed Central
Google Scholar
Walker UA, Tyndall A, Czirják L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis. 2007;66(6):754–63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kawut SM, Taichman DB, Archer-Chicko CL, Palevsky HI, Kimmel SE. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest. 2003;123(2):344–50.
Article
PubMed
Google Scholar
Simpson CE, Damico RL, Hummers L, Khair RM, Kolb TM, Hassoun PM, et al. Serum uric acid as a marker of disease risk, severity, and survival in systemic sclerosis-related pulmonary arterial hypertension. Pulm Circ. 2019;9(3):2045894019859477.
Article
PubMed
PubMed Central
CAS
Google Scholar
Chaisson NF, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Chest. 2013;144(4):1346–56.
Article
PubMed
PubMed Central
Google Scholar
Chung L, Domsic RT, Lingala B, Alkassab F, Bolster M, Csuka ME, et al. Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry. Arthritis Care Res (Hoboken). 2014;66(3):489–95.
Article
Google Scholar
Hao Y, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C, et al. A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Res Ther. 2015;17(1):7.
Article
PubMed
PubMed Central
Google Scholar
Giacomelli R, Liakouli V, Berardicurti O, Ruscitti P, Di Benedetto P, Carubbi F, et al. Interstitial lung disease in systemic sclerosis: current and future treatment. Rheumatol Int. 2017;37(6):853–63.
Article
PubMed
Google Scholar
Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119.
Article
PubMed
Google Scholar
Warwick G, Thomas PS, Yates DH. Biomarkers in pulmonary hypertension. Eur Respir J. 2008;32(2):503–12.
Article
CAS
PubMed
Google Scholar
McHugh NJ, Distler O, Giacomelli R, Riemekasten G. Non organ based laboratory markers in systemic sclerosis. Clin Exp Rheumatol. 2003;21(3 Suppl 29):S32–S8.
CAS
PubMed
Google Scholar
Cipriani P, Di Benedetto P, Ruscitti P, Campese AF, Liakouli V, Carubbi F, et al. Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features. Arthritis Res Ther. 2014;16(15):442.
Article
PubMed
PubMed Central
Google Scholar
Vaillancourt M, Ruffenach G, Meloche J, Bonnet S. Adaptation and remodelling of the pulmonary circulation in pulmonary hypertension. Can J Cardiol. 2015;31(4):407–15.
Article
PubMed
Google Scholar
Di Benedetto P, Ruscitti P, Liakouli V, Del Galdo F, Giacomelli R, Cipriani P. Linking myofibroblast generation and microvascular alteration: the role of CD248 from pathogenesis to therapeutic target. Mol Med Rep. 2019;20(2):1488–98.
CAS
PubMed
Google Scholar
Di Benedetto P, Liakouli V, Ruscitti P, Berardicurti O, Carubbi F, Panzera N. Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy. Arthritis Res Ther. 2018;20(1):223.
Article
PubMed
PubMed Central
CAS
Google Scholar
Cipriani P, Di Benedetto P, Ruscitti P, Capece D, Zazzeroni F, Liakouli V, et al. The endothelial-Mesenchymal transition in SSc is induced by the synergistic effect of ET-1 and TGF-β and may be blocked by macitentan, a new dual ET-1 receptor antagonist. J Rheumatol. 2015;42(10):1808–16.
Article
CAS
PubMed
Google Scholar
Cipriani P, Marrelli A, Di Benedetto P, Liakouli V, Carubbi F, Ruscitti P, et al. Scleroderma Mesenchymal stem cells display a different phenotype from healthy controls; implications for regenerative medicine. Angiogenesis. 2013;16(3):595–607.
Article
CAS
PubMed
Google Scholar
Dinarello CA, Kim SH. IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis. 2006;65(Suppl 3):iii61–4.
PubMed
PubMed Central
Google Scholar
Nold-Petry CA, Nold MF, Zepp JA, Kim SH, Voelkel NF, Dinarello CA. IL-32-dependent effects of IL-1b on endothelial cell functions. Proc Natl Acad Sci U S A. 2009;106(10):3883–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nold-Petry CA, Rudloff I, Baumer Y, Ruvo M, Marasco D, Botti P, et al. IL-32 promotes angiogenesis. J Immunol. 2014;192:589–602.
Article
CAS
PubMed
Google Scholar
Choi JD, Bae SY, Hong JW, Azam T, Dinarello CA, Her H, et al. Identification of the most active interleukin-32 isoform. Immunology. 2009;126(4):535–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Heinhuis B, Netea MG, van den Berg WB, Dinarello CA, Joosten LA. Interleukin-32: a predominantly intracellular proinflammatory mediator that controls cell activation and cell death. Cytokine. 2012;60(2):321–7.
Article
CAS
PubMed
Google Scholar
Manetti M, Ibba-Manneschi L, Liakouli V, Serena Guiducci, Anna Franca Milia, Gemma Benelli et al. the IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis. Ann Rheum Dis 2010;69(3):598–605.
Ciccia F, Alessandro R, Rizzo A, Raimondo S, Giardina A, Raiata F, et al. IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis. Ann Rheum Dis. 2013;72:258–64.
Article
CAS
PubMed
Google Scholar
Ciccia F, Rizzo A, Ferrante A, Guggino G, Croci S, Cavazza A, et al. New insights into the pathogenesis of giant cell arteritis. Autoimmun Rev. 2017;16(7):675–83.
Article
CAS
PubMed
Google Scholar
Ciccia F, Alessandro R, Rizzo A, Principe S, Raiata F, Cavazza A, et al. Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis. Arthritis Rheum. 2001;63(7):2097–104.
Article
CAS
Google Scholar
Ciccia F, Rizzo A, Accardo-Palumbo A, Giardina A, Bombardieri M, Guggino G, et al. Increased expression of interleukin-32 in the inflamed ileum of Ankylosing spondylitis patients. Rheumatology (Oxford). 2012;51(11):1966–72.
Article
CAS
Google Scholar
Alsaleh G, Sparsa L, Chatelus E, Ehlinger M, Gottenberg JE, Wachsmann D, et al. Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther. 2010;12(4):R135.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ha YJ, Park JS, Kang MI, Lee SK, Park JB, Sang-Won Lee SW. Increased serum interleukin-32 levels in patients with Behçet’s disease. Int J Rheum Dis. 2018;21(12):2167–74.
Article
CAS
PubMed
Google Scholar
Kitayama N, Otsuka A, Nonomura Y, Nakashima C, Honda T, Kabashima K. Decrease in serum IL-32 level in patients with atopic dermatitis after cyclosporine treatment. J Eur Acad Dermatol Venereol. 2017;31(10):e449–50.
Article
CAS
PubMed
Google Scholar
Kwon OC, Ghang B, Lee EJ, Hong S, Lee CK, Yoo B, Kim S, Kim YG. Interleukin-32γ: possible association with the activity and development of nephritis in patients with systemic lupus erythematosus. Int J Rheum Dis. 2019;22(7):1305–11.
Article
CAS
PubMed
Google Scholar
Khanna D, Furst DE, Clements PJ, Allanore Y, Baron M, Czirjak L, et al. Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord. 2017;2(1):11–8.
Article
PubMed
Google Scholar
LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202–5.
CAS
PubMed
Google Scholar
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;65(11):2737–47.
Google Scholar
Fisher MR, Forfia PR, Chamera E, Housten-Harris T, Champion HC, Girgis RE, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med. 2009;179(7):615–21.
Article
PubMed
PubMed Central
Google Scholar
Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. Rev J Am Coll Cardiol. 2004;43(12 Suppl S):40S–7S.
Article
Google Scholar
Nagel C, Henn P, Ehlken N, D'Andrea A, Blank N, Bossone E, Böttger A, Fiehn C, Fischer C, Lorenz HM, Stöckl F, Grünig E, Egenlauf B. Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension. Clin Trial Arthritis Res Ther. 2015;17(1):165.
Article
Google Scholar
Kahaleh MB, Sultany GL, Smith EA, Huffstutter JE, Loadholt CB, Le Roy EC. A modified scleroderma skin scoring method. Clin Exp Rheumatol. 1986;4(4):367–9.
CAS
PubMed
Google Scholar
García-Hernández FJ, Castillo-Palma MJ, Tolosa-Vilella C, Guillén-del Castillo A, Rubio-Rivas M, Freire M, et al. Pulmonary hypertension in Spanish patients with systemic sclerosis. Data from the RESCLE registry. Clin Rheumatol. 2019;38(4):1117–24.
Article
PubMed
Google Scholar
Iudici M, Codullo V, Giuggioli D, Riccieri V, Cuomo G, Breda S, et al. Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort. Clin Exp Rheumatol. 2013;31(2 Suppl 76):31–6.
PubMed
Google Scholar
Denton CP, Hachulla E. Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening. Eur Respir Rev. 2011;20(122):270–6.
Article
CAS
PubMed
Google Scholar
Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, Moinzadeh P, et al. The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford). 2008;47(8):1185–92.
Article
CAS
Google Scholar
Meyer N, Christoph J, Makrinioti H, Indermitte P, Rhyner C, Soyka M, et al. Inhibition of angiogenesis by IL-32: possible role in asthma. J Allergy Clin Immunol. 2012;129(4):964–73.e7.
Article
CAS
PubMed
Google Scholar
Sloot YJE, Smit JW, Joosten LAB, Netea-Maier RT. Insights into the role of IL-32 in cancer. Semin Immunol. 2018;38:24–32.
Article
CAS
PubMed
Google Scholar
Fadaei R, Bagheri N, Heidarian E, Ali Nouri, Zahra Hesari, Nariman Moradi et al. Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-α and IL-6. Cytokine 2020;125:154832.
Rafiei A, Mohammadjafari H, Ahifar A, Alipour A, Mirabi AM. The urinary and serum levels of IL-32 in children with febrile urinary tract infections. Future Sci OA. 2017;3(4):FSO242.
Article
CAS
PubMed
PubMed Central
Google Scholar
Greiner S, Jud A, Aurich M, Hess A, Hilbel T, Hard S, et al. Reliability of non invasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterization: analysis in a large patient population. J Am Heart Assoc. 2014;3(4):e001103.
Article
PubMed
PubMed Central
Google Scholar
Giacomelli R, Afeltra A, Alunno A, Bartoloni-Bocci E, Berardicurti O, Bombardieri M, et al. Guidelines for biomarkers in autoimmune rheumatic diseases-evidence based analysis. Autoimmun Rev. 2019;18(1):93–106.
Article
CAS
PubMed
Google Scholar
Riccieri V, Vasile M, Iannace N, Stefanantoni K, Sciarra I, Vizza CD, et al. Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study. Rheumatology (Oxford). 2013;52(8):1525–8.
Article
CAS
Google Scholar
Huang SJ, McLean AS. Appreciating the strengths and weaknesses of transthoracic echocardiography in hemodynamic assessments. Cardiol Res Pract. 2012;2012:894308.
Article
PubMed
PubMed Central
Google Scholar
Suga H, Sugaya M, Miyagaki T, Kawaguchi M, Fujita H, Asano Y, et al. The role of IL-32 in cutaneous T-cell lymphoma. J Invest Dermatol. 2014;134(5):1428–35.
Article
CAS
PubMed
Google Scholar
Cifone GM, Giacomelli R, Famularo G, Paolini R, Danese C, Napolitano T, et al. Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis. Clin Exp Immunol. 1990;80(3):360–5.
Article
Google Scholar
Giacomelli R, Cipriani P, Fulminis A, Barattelli G, Matucci-Cerinic M, D'Alò S, et al. Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization. Clin Exp Immunol. 2001;125(2):310–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lescoat A, Lecureur V, Roussel M, Sunnaram BL, Ballerie A, Coiffier G, et al. CD16-positive circulating monocytes and fibrotic manifestations of systemic sclerosis. Clin Rheumatol. 2017;36(7):1649–54.
Article
PubMed
Google Scholar
Klein M, Schmalzing M, Almanzar G, Benoit S, Hamm H, Tony HP, et al. Contribution of CD8+ T cells to inflammatory cytokine production in systemic sclerosis (SSc). Autoimmunity. 2016;49(8):532–46.
Article
CAS
PubMed
Google Scholar
Meyer N, Zimmermann M, Bürgler S, Bassin C, Woehrl S, Moritz K, et al. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol. 2010;125(4):858–65.
Article
CAS
PubMed
Google Scholar
Matsuda KM, Yoshizaki A, Kuzumi A, Fukasawa T, Ebata S, Miura S. Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study. Arthritis Res Ther. 2019;21(1):129.
Article
PubMed
PubMed Central
Google Scholar
Dobrota R, Maurer B, Graf N, Jordan S, Mihai C, Kowal-Bielecka O, et al. Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis. Ann Rheum Dis. 2016;75(10):1743–8.
Article
CAS
PubMed
Google Scholar